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ABSTRACT
G-DNA, a polymorphic family of four-stranded DNA
structures, has been proposed to play roles in a variety
of biological processes including telomere function,
meiotic recombination and gene regulation. Here we
report the purification and cloning of TGP1, a G-DNA
specific binding protein from Tetrahymena thermophila.
TGP1 was purified by three-column chromatographies,
including a G-DNA affinity column. Two major proteins
(∼80 and ∼40 kDa) were present in the most highly
purified column fraction. Renaturation experiments
showed that the ∼80 kDa protein contains TGP1 activity.
Biochemical characterization showed that TGP1 is a
G-DNA specific binding protein with a preference for
parallel G-DNAs. The TGP1/DNA complex has a
dissociation constant (Kd) of ∼2.2 × 10–8 M and TGP1 can
form supershift in gel mobility shift assays. The cDNA
coding TGP1 was cloned and sequenced based upon an
internal peptide sequence obtained from the ∼80 kDa
protein. Sequence analyses showed that TGP1 is a basic
protein with a pI of 10.58, and contains two extensively
hydrophilic and basic domains. Homology searches
revealed that TGP1 is a novel protein sharing weak
similarities with a number of proteins.
INTRODUCTION
G-quartets are unusual nucleic acid structures first described
about three decades ago (reviewed in 1). In a G-quartet, four
guanine molecules lie in a plane with each guanine forming G:G
(instead of Watson–Crick A:T or G:C) hydrogen bonds with two
adjacent guanines (1–3). DNA containing such structures is
known as quadruplex, tetraplex or G-DNA (3). Many guanine-rich
sequences of biological significance have been found to be
capable of forming G-quartet structures in vitro under physiological
conditions. Such G-rich sequences include most telomeres (4–6),
immunoglobulin switch regions (7), a few gene promoters
(8–10), fragile X repeats (11) and the dimerization domain in the
human immunodeficiency virus (HIV) genome (12,13).
The ability to form G-DNA by these important sequences implies
that G-DNA may be biologically relevant. However, direct evidence
for the existence of G-DNA in vivo is lacking. An alternative
approach to study G-DNA is to identify and investigate proteins that
interact with this structure. A number of proteins have been found
to be able to bind to G-DNA. These proteins include a hepatocyte
chromatin protein QUAD (14), transcription factor MyoD (15),
chick topoisomerase II (16), two yeast proteins G4p1 and G4p2
(17,18) and the yeast KEM1 protein (19). In contrast to all other
G-DNA binding proteins, KEM1 not only binds to G-DNA, but also
acts as a nuclease to cut the single-stranded DNA 5′ to the G-quartet
domain (19,20). The G-DNA specific nuclease activity of KEM1,
together with the studies in which meiotic recombination was found
to be severely affected in KEM1 deletion mutants (21,22), suggests
that KEM1 and the G-DNA structure play roles in meiotic pairing
(20). In addition to G-DNA binding proteins, two proteins have been
found to facilitate the formation of G-DNA structure: the Oxytricha
telomere binding protein β subunit, which acts as a molecular
chaperone (23,24), and the multifunctional yeast telomere protein
RAP1 (25). Since both proteins are telomere-related, their G-DNA
promotion activities suggest that G-DNA may have a role in
telomere function.
The biological relevance of G-DNA was further suggested by
several other studies showing that G-DNA can inhibit the
activities of a number of proteins. One of these G-DNA-inhibited
proteins is telomerase, the enzyme that synthesizes telomeres
(26). It was found that folding of telomere DNA (specifically the
primer) into G-DNA inhibited the activity of telomerase in vitro,
suggesting that formation of G-DNA in the primer could
down-regulate telomere elongation in vivo (27). Another in vitro
study showed that an antiparallel G-DNA aptamer can inhibit
thrombin activity (28). G-DNA was also shown to inhibit the
activity of macrophage scavenger receptors, the glycoproteins which
may function in the deposition of lipoprotein cholesterol (29). More
interestingly, an oligonucleotide in G-DNA form was found to be a
potent inhibitor of HIV-1 integrase (30). These inhibitory activities
of G-DNA suggest its potential use as a pharmaceutical agent.
Possible biological functions for G-DNA are diverse, but remain
to be definitively demonstrated. Further studies on G-DNA and its
related proteins are needed to elucidate the exact role(s) of these
structures in vivo. The ciliated protozoan, Tetrahymena thermophila,
has proven to be a useful system for identification of G-DNA
binding proteins. This organism has two nuclei, one of which
contains a fragmented genome with thousands of telomeres (31). A
relatively abundant G-DNA binding activity has been identified in
T.thermophila (32). The protein, TGP1 (Tetrahymena G-DNA
binding protein 1), binds to an intermolecular G-DNA form of
d(TTGGGG)4 under physiological conditions, and competition
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Table 1. Oligonucleotides used in mobility shift and competition assays
(oligo GL is from ref. 17)
experiments showed that G-DNAs competed strongly for TGP1
binding, while non-G-DNA and G-RNA oligonucleotides did not
(32). In this paper, we report the purification, molecular cloning
and further biochemical characterization of TGP1. TGP1 was
shown to be an 83 kDa protein with binding activity specific for
G-DNA. Complete cDNA sequence of TGP1 was obtained and
shown to encode a novel protein with two extensively hydrophilic
and basic putative DNA binding domains and weak similarities to
a number of other proteins. In light of these data, possible functions
for TGP1 are discussed.
MATERIALS AND METHODS
Oligonucleotide synthesis, purification and labeling
Oligonucleotides (oligos) (Table 1) were synthesized on an ABI
394 DNA/RNA synthesizer (ISU DNA facility), and purified as
previously described (32). Briefly, oligos were separated on a
20% denaturing polyacrylamide gel (7 M urea), then desired oligo
products were excised and purified by C-18 chromatography
(Waters). 5′-32P-labeling of oligos using T4 polynucleotide kinase
was carried out according to a standard protocol (33). Radiolabeled
oligos were purified by G-25 spin columns (5 prime→3 prime).
Mobility shift experiments and competition assays
Fifty nanograms of 32P-labeled oligo Y were boiled for 3 min in
G-DNA formation buffer (50 mM KCl, 10 mM MgCl2, 10 mM
Tris–HCl, pH 8.0, 5% glycerol), cooled and incubated at room
temperature for at least 30 min to make G-DNA. Mobility shift
experiments were performed as previously described with minor
modifications (32). About 2.5 ng of labeled Y(G4) were mixed
with desired amounts of protein extract or TGP1 fractions in
binding reaction buffer (10 mM Tris–HCl, pH 7.5, 6% glycerol).
One hundred fold (∼250 ng) non-specific competitor poly(dI·dC)
(Pharmacia) was added to each binding reaction. The total volume
of each reaction was 20 µl. After incubation on ice for 20 min, the
reaction mixtures were loaded onto a 6% polyacrylamide gel.
Electrophoresis was carried out in 0.6× TBE at room temperature.
The gel was then vacuum-dried, and exposed to X-ray film or a
PhosphorImager screen (Molecular Dynamics).
For competition assays, unlabeled competitors were made as
follows. Single-stranded DNA (Y) was made by boiling in
ddH2O for 3 min to prevent G-quartet structure formation, and
chilling on ice for 30 min. Double-stranded DNAs (Y-cY,
Tet4-cTet4) were formed by annealing of single-stranded oligos with
their complementary strands at 95C for 5 min, 65C for 10 min and
37C for 10 min in buffer containing 50 mM NaCl and 10 mM
Tris–HCl, pH 7.5. G-DNAs were formed according to the
methods described by Sen and Gilbert (34). In mobility shift
assays, unlabeled competitors were diluted as indicated and
added to the binding buffer before the addition of TGP1 and
labeled Y(G4) probe. About 50 ng of TGP1 and saturating
amounts (2.5 ng) of labeled probe Y(G4) were used in each
binding reaction. Twenty units of RNasin ribonuclease inhibitor
(Promega) were included in reactions where RNA oligo (rTet4)
was used. Binding reactions and mobility shift experiments were
performed as described above.
SDS–PAGE and silver staining
SDS–PAGE was performed according to the standard protocol
(33). After electrophoresis, protein bands were visualized by
silver staining following the manufacturer’s protocol (BioRad).
UV cross-linking
Cross-linking of G-DNA to TGP1 was performed in situ by
exposing a wet 8% mobility shift gel on ice to 254 nm UV light
with the gel no more than 5 cm from the UV source. The gel was
then exposed to film to reveal the position of the TGP1/G-DNA
binding complex. The gel piece containing the complex was
excised, denatured in SDS sample buffer for 5 min, and
polymerized into the stacking gel of a 10% SDS–polyacrylamide
gel. After electrophoresis, the gel was dried and exposed to X-ray
film. Molecular weight markers were included to identify the
positions of cross-linked bands.
Tetrahymena cell culture and extract preparation
Tetrahymena cell culture and total protein extract preparation were
performed as previously described (32). Briefly, T.thermophila cells
(strain C3V) were grown vegetatively to mid-log phase (2.5 ×
105 cells/ml) and harvested. Cells were washed twice with
10 mM Tris–Cl, pH 7.5, resuspended in 5 volumes of TMG buffer
(10 mM Tris–Cl, pH 7.5, 1 mM MgCl2, 10% glycerol and 10 mMβ-mercaptoethanol) with protease inhibitors (0.01 mM Leupeptin,
0.01 mM Pepstatin and 0.1 mM Pefabloc, all from Boehringer-
Mannheim), and lysed by addition of one tenth volume of
2% NP-40 (Sigma). The cell lysate was centrifuged at 100 000 g
for 70 min. The supernatant (S100) was aliquoted, immediately
frozen in liquid nitrogen and stored at –70C.
Purification of TGP1
All purification steps were conducted at 4C unless otherwise
indicated. Tetrahymena S100 protein extract (100 ml, ∼10 mg/ml)
was quickly thawed and filtered through a 0.4 µm filter (Costar). The
filtrate was then loaded onto a SP-Sepharose column (4.91 cm2 ×
14.5 cm, Pharmacia), which had been equilibrated and packed with
at least 2 column volumes of chromatography buffer [CB buffer:
10 mM Tris–HCl, pH 7.7, 1 mM EDTA, 0.01% NP-40, 10%
glycerol and 1 mM dithiothreitol (DTT)], at a flow rate of
0.8 ml/min. After the extract had passed through the column,
1.5 column volumes of CB buffer were passed through the column
at the same flow rate (0.8 ml/min). The column was then washed
with 2 column volumes of CB buffer containing 0.45 M NaCl at a
flow rate of 2 ml/min to remove weakly bound proteins. Four
column volumes of CB buffer containing 0.8 M NaCl were then
applied to elute TGP1 activity. About sixty 3 ml fractions were
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collected and assayed for TGP1 activity in mobility shift
experiments.
Fractions from the SP-Sepharose column containing TGP1
activity were pooled and dialyzed against CB buffer overnight at
4C. The fractions were then loaded at a flow rate of 0.5 ml/min
onto a DE52 column (3.21 cm2 × 4 cm, Whatman), which had been
equilibrated with CB buffer. The column was then washed with
1 column volume of CB buffer at a rate of 0.5 ml/min. A linear NaCl
gradient (0–0.8 M in CB buffer, 2 column volumes) was applied to
elute TGP1 activity at a flow rate of 0.4 ml/min. About thirty 2 ml
fractions were collected and assayed in mobility shift experiments.
A G-DNA affinity column (∼2 ml) was constructed according
to a published procedure (20) with minor modifications. Briefly,
200 µg of 3′-biotinylated oligo Y (Midland) were mixed with 1 mg
of oligo Y (5-fold) in the presence of 10 mM MgCl2 and 100 mM
KCl. The mixture was boiled for 3 min and then cooled to room
temperature for 30 min to allow G-DNA formation. The biotinylated
Y(G4) was then mixed with 2 ml of 50% avidin-agarose (Pierce),
which had been equilibrated with CB buffer containing 100 mM
KCl. After incubation at room temperature for 1 h, the mixture
was poured and packed into a 5 ml disposable column (BioRad).
Fractions from the DE52 column containing TGP1 activity were
pooled and dialyzed against CB buffer overnight at 4C. The
fractions were then loaded at a flow rate of 0.1 ml/min onto the
G-DNA affinity column, which had been equilibrated with CB
buffer containing 0.1 M KCl. After the sample passed through,
the column was washed with 1 column volume of 0.1 M KCl/CB
buffer, and proteins were eluted with a linear KCl gradient
(0.1–2.0 M) in CB buffer. About thirty 0.2 ml fractions were
collected and tested for TGP1 activity in mobility shift experiments.
Protein renaturation
Renaturation experiments were performed using a procedure similar
to that described by Hager and Burgess (35). Briefly, partially
purified TGP1 (∼10 µg) was displayed on a 10% SDS–PAGE, and
the gel was then stained with Coomassie blue. Gel slices containing
different protein bands were excised, rinsed with ddH2O, put into
different tubes, and crushed into small pieces. One milliliter of
elution buffer (50 mM Tris–HCl, pH 7.5, 0.1% SDS, 0.1 mg/ml
BSA, 1 mM DTT, 0.2 mM EDTA and 2.5% glycerol) was then
added to each tube. Proteins were eluted from the gel into buffer with
agitation for at least 2 h at room temperature. The mixtures were
centrifuged for 2 min at 10 000 r.p.m. Supernatants were transferred
to fresh tubes, mixed with 4 volumes of 100% acetone (–20C),
stored at –20C for >2 h and centrifuged for 10 min at 10 000 r.p.m.
Precipitates were rinsed with 0.5 ml of 100% methanol (–20C)
twice, air dried and dissolved in 5 ml of 6 M guanidine-HCl in
dilution buffer (50 mM Tris–HCl, pH 7.6, 20% glycerol, 0.1 mg/ml
BSA, 0.15 M NaCl, 1 mM DTT and 0.1 mM EDTA) for 20 min at
room temperature. Solutions were 50-fold diluted with dilution
buffer, and proteins were allowed to renature overnight at room
temperature. Renatured proteins were tested for TGP1 activity in
mobility shift experiments.
Kd determination of TGP1/G-DNA binding complex
Affinity purified TGP1 fractions were pooled, dialyzed against
CB buffer and concentrated using Centricon concentrators
(Amicon). TGP1 protein concentrations were estimated by
SDS–PAGE and Coomassie blue staining. Concentrated TGP1
was then serially-diluted 2-fold and used in mobility shift
experiments. Bound and unbound Y(G4) probe was quantitated
by a PhosphorImager (Molecular Dynamics). The Kd for TGP1
G-DNA binding reaction was estimated from the plot of
percentage of bound Y(G4) versus protein concentration.
Peptide sequencing
Purified TGP1 from affinity column was displayed on a 10%
SDS–PAGE and electrotransferred to PVDF membrane according
to the manufacturer’s protocol (BioRad). The 80 kDa band was
excised and N-terminal sequencing was attempted (ISU Protein
Facility), but failed due to N-terminal blockage, thus internal
peptide sequencing was then performed. About 5 µg of TGP1
(80 kDa) was eluted from 10% SDS–PAGE gel and acetone
precipitated (see the Renaturation section for details). The protein
was then subjected to CNBr digestion according to the protocol
described by Smith (36). After digestion, peptides were resolved
on a 16% SDS–PAGE, and transferred to PVDF membrane. One
of the peptides (∼35 kDa) yielded a clear peptide sequence:
??GRQSAEG?VG?hYIEV?rFgQYi (‘?’ indicates that no amino
acid had been assigned, while letters in lower case indicate
tentative assignments).
Molecular cloning of TGP1 cDNA
Total RNA was isolated from mid-log phase T.thermophila cells
using TRIzol reagent according the manufacturer’s protocol
(Gibco-BRL). First strand cDNA synthesis from total RNA was
done by reverse transcription using the M-MLV reverse
transcriptase (Gibco-BRL). Based on the internal peptide sequence
and with consideration of Tetrahymena genetic codon usage (37),
two partially degenerate primers were designed: primer 1
[5′-GGTAGA(C/T)A(A/G)(T/A)(C/G)(T/C)GC(T/C)GAAGG]
corresponding to the peptide sequence GRQSAEG, and primer 2
[5′-AATCTGCA(A/G)ACTTC(A/G)AT(A/G)TA] corresponding
to the antisense sequence of peptide YIEV?rF. PCR was
performed using the first strand cDNAs and primer 1 and primer
2. The PCR product (∼55 bp) was cloned into TA cloning vector
(Invitrogen), and sequenced (ISU DNA Facility).
Both 5′ and 3′ rapid amplification of cDNA ends (RACE) were
performed according to the recommended protocols (Gibco-BRL).
For 3′ RACE, a TGP1 gene specific primer (primer 3:
5′-GCTGAAGGAAAAGTCGGTGGTCAC) was designed
based on the sequence of the 55 bp PCR product. First strand cDNA
synthesis was done using the poly(dT)-anchor oligo (Gibco-BRL).
Subsequent PCR was performed over the first strand cDNAs using
the anchor and primer 3. PCR products were cloned and sequenced.
For 5′ RACE, the first strand cDNA synthesis was done using a gene
specific primer (primer 4: 5′-TTGACCGAATTTCTTAACTT-
CG), which was based on the DNA sequence obtained in the
3′ RACE. After that, the first strand cDNAs were tailed with
poly(dC), and purified. PCR was performed over the tailed
cDNAs using a poly(dG)-anchor primer and a nested gene
specific primer (primer 5: 5′-TAGTGACCACCGACTTTTCC)
as primers. PCR products were cloned and sequenced.
Sequence analyses and database searches 
GCG (Genetics Computer Group, Inc.) software was used for
sequence analyses. BLAST (38) and FASTA (39) database
searches were performed at the National Center for Biotechnology
 Nucleic Acids Research, 1998, Vol. 26, No. 71616
Figure 1. UV cross-linking assay to estimate the molecular weight of TGP1.
Radiolabeled Tet4(G4) was cross-linked to TGP1 in situ. The band containing
the cross-linked complex was excised from a mobility shift assay gel and
polymerized into a 10% SDS–PAGE gel for size estimation. The –UV/–Pro and
+UV/–Pro lanes contained probe alone without and with UV treatment
respectively. The +UV/+Pro lanes contained protein/DNA complexes exposed
to UV for different amounts of time (in minutes). The main cross-linked
complex had an apparent MW of ∼95 kDa. A minor complex ∼45 kDa was also
observed with longer UV exposure times.
Information (NCBI). Secondary structure analysis was done at
the European Molecular Biology Laboratory (EMBL).
RESULTS
Identification of TGP1 by UV cross-linking
To identify proteins responsible for TGP1 activity, UV cross-linking
experiments were performed. For these experiments, Tet4(G4)
probe and a saturating amount of S100 extract were used. The
results are shown in Figure 1. There were no detectable bands in
samples which were not exposed to UV-light and which did not
contain both the protein extract and probe. In contrast, a band of
∼95 kDa was observed in UV-exposed samples containing both the
protein extract and DNA probe. These results suggested that the
95 kDa band was the cross-linked complex between TGP1 and
DNA probe. Depending on how many Tet4 monomers cross-
linked to TGP1, the molecular weight (MW) of the protein can range
from 61 to 87 kDa (the Tet4 monomer has a MW ∼8.4 kDa). As UV
exposure time increased, a minor cross-linked product ∼45 kDa
was observed. This 45 kDa band could have resulted from a
degradation product of the 95 kDa band, or may represent a
different protein. Subsequent experiments (affinity purification
and renaturation) suggested that this band represents a different
G-DNA binding protein.
Purification of TGP1
A number of chromatography columns were tested on analytical
scales (1–10 ml) to determine their usefulness in purifying TGP1.
Three columns (SP-Sepharose, DE52 and G-DNA affinity) were
chosen for the purification. The first column used, SP-Sepharose,
is a cation-exchange column (Fig. 2A). As shown in the mobility
shift assay, TGP1 was eluted when the salt concentration reached
0.8 M NaCl. This column resulted in removal of >90% of
non-TGP1 proteins (data not shown). The high salt concentration
(0.8 M NaCl) needed to elute TGP1 activity suggested that TGP1
is a basic protein, or may contain basic domains. After the
SP-Sepharose column, the TGP1 fractions were applied to an
anion-exchange (DE52) column (Fig. 2B). TGP1 activity was
eluted from the column at NaCl concentrations of 0.15–0.5 M.
To further purify TGP1, a G-DNA affinity column was used.
After elution from this column, the fractions were subjected to
both mobility shift assay and SDS–PAGE silver staining. As
shown in Figure 3A, TGP1 activity was eluted between 0.6 and
Figure 2. SP-Sepharose and DE52 column purification of TGP1. (A) SP-Sepharose column purification. S100 extracts of vegetatively grown Tetrahymena mid-log
phase cells (2.5 × 105/ml) were loaded onto a ∼50 ml SP-Sepharose column (Pharmacia). Stepwise NaCl was applied to elute the proteins. Following purification,
the fractions were tested for TGP1 activity in mobility shift experiments. Most of the TGP1 activity eluted from the column when 0.8 M NaCl was applied (fractions
48–52). (B) DE52 column purification. The TGP1 fractions from SP-Sepharose column were pooled, dialyzed against CB buffer overnight and loaded onto a ∼10 ml
DE52 (Whatman) column. Proteins were eluted using a linear salt gradient (0–0.8 M NaCl). TGP1 activity was followed by mobility shift assays.
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Figure 3. G-DNA affinity column purification of TGP1. The TGP1 fractions
from DE52 column were pooled, dialyzed and applied to a 1 ml G-DNA
column. (A) A KCl gradient (0–2.0 M) was used to elute proteins from the
column. The fractions were tested for TGP1 activity by mobility shift assays.
TGP1 activity was eluted at 0.8–1.0 M KCl. The fractions were also tested by
SDS–PAGE and silver staining (B) to determine protein components in each
fraction. Two major bands (∼80 and ∼40 kDa) were found in the silver stained
gel. The pattern of the 80 kDa band matched that of the TGP1 activity.
Figure 4. Renaturation of TGP1 activity from SDS–PAGE gel. Proteins (80, 50,
40 and 30 kDa) from SDS–PAGE gel were allowed to renature according to the
procedure described in the Materials and Methods. Renatured proteins were
tested for TGP1 activity in mobility shift assays (native TGP1 was used in the
control lane).
1.0 M KCl with a peak at 0.8 M KCl. In the silver staining (Fig. 3B),
two major bands (∼80 and ∼40 kDa) were present in the TGP1
peak fraction. However, the 80 kDa band pattern in the silver
staining correlated best with TGP1 activity shown in the mobility
shift assay, suggesting that the 80 kDa band is responsible for
TGP1 activity. The 40 kDa protein may correlate with the lower
shifted bands in the mobility shift assay.
Renatured ∼80 kDa protein contains TGP1 activity
To confirm that the 80 kDa protein was TGP1, renaturation of
proteins from SDS–PAGE was performed. The renatured proteins
Figure 5. TGP1 G-DNA binding specificity. In competition assays, 2.5 ng of
labeled Y(G4) was used as probe. Appropriate amounts of purified TGP1 were
used to keep the Y(G4) probe saturated (excessive probe). Unlabeled competitors
were diluted (2-, 5-, 10-, 50- and 100-fold) and used in mobility shift assays, as
described in the methods section. The nomenclature of different G-quartet forms
was according to Sen and Gilbert (34): G4, G′4 and G′2 denote intermolecular
parallel, intramolecular foldback, and antiparallel dimer G-quartets, respectively.
were used in mobility shift experiments to assay for TGP1
activity. The results (Fig. 4) showed that the protein renatured
from the 80 kDa band had TGP1 activity, while no shifted bands
were observed for two control proteins (50 and 30 kDa). These
results demonstrated that the 80 kDa band contains the TGP1
protein. The size of TGP1 (80 kDa) is consistent with that
predicted by the UV cross-linking experiment. Interestingly, a
strong band that shifted to a position lower than the TGP1/G-
DNA complex was observed for the renatured 40 kDa protein. To
test whether there are any interactions between the 80 and 40 kDa
proteins, we mixed both renatured proteins and tested them in the
mobility shift assay. No additional shifted bands were observed,
suggesting no obvious interactions between these two proteins.
However, this result does not rule out the possibility of
interactions between these two proteins, because the proteins
used in the assay were likely to have been only partially renatured.
TGP1 binds specifically to G-DNA
The DNA binding specificity of TGP1 was studied by competition
assays using purified TGP1. Oligonucleotides used in the assays are
listed in Table 1. The results are shown in Figure 5. The strongest
competitors for TGP1 G-DNA binding are GL(G4), Tet(G4) and
Y(G4). These three oligos are in the intermolecular parallel G-DNA
(G4) form, suggesting that TGP1 has high binding affinity for such
a structure. Non-G-DNAs, including single-stranded DNA (Y) and
double-stranded DNAs (Y-cY, Tet4-cTet4), did not compete for
TGP1 binding under our assay conditions. Antiparallel G-DNAs
(G4′ and G′2) showed intermediate competition between those of
parallel G-DNAs and non-G-DNAs. G-RNA rTet4(G4) was also
tested for competition, and showed much weaker competitive
activity than its DNA counterpart Tet4(G4). Hence, our competition
results demonstrate that TGP1 is a G-quartet structure-specific
binding protein that prefers G-DNAs in the parallel form.
TGP1/G-DNA complex has a Kd of 2.2 × 10–8 M
Purified TGP1 was also used to determine the Kd of the
TGP1/G-DNA complex. The result of the mobility shift assay using
serially-diluted (2-fold) TGP1 is shown in Figure 6A. A supershift
band was observed when high concentrations of TGP1 were used.
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Figure 6. Kd determination of TGP1 G-DNA binding. (A) Mobility shift assays
were carried out with 2.5 ng Y(G4) probe and 2-fold serial-diluted TGP1 (the
highest TGP1 concentration was ∼1 µg per reaction). A supershift band was
observed when TGP1 of high concentrations was used. (B) Kd estimation. The
mobility shift gel (A) was quantitated using a PhosphorImager (Molecular
Dynamics). The data were plotted and a Kd of ∼2.2 × 10–8 M was determined
from the graph.
With TGP1 at low concentration, the supershift band disappeared.
This supershift could be a dimer of TGP1 binding to a G-DNA
substrate. However, because the TGP1 fraction used in the assay
contains other proteins (mainly the 40 kDa protein), it is possible that
other protein components may be involved in forming such a
supershift band. Bands in the mobility shift gel were quantitated and
the data were plotted in the graph shown in Figure 6B. The estimated
Kd for TGP1/G-DNA binding is ∼2.2 × 10–8 M, under our assay
conditions [2.5 ng Y(G4) probe, 10 mM Tris–HCl, pH 7.5, 4C].
This Kd value is in a range similar to those of other G-DNA binding
proteins such as G4p1 (17) and G4p2 (18).
Molecular cloning of TGP1 cDNA
To clone the cDNA coding the TGP1 protein, peptide sequencing
was performed. No sequence data were obtained from the
N-terminal sequencing directly from TGP1, possibly due to
N-terminal blockage (data not shown). However, a 35 kDa
peptide obtained from CNBr digestion of TGP1 yielded an amino
acid sequence (??GRQSAEG?VG?hYIEV?rFgQYi).
TGP1 cDNA was cloned based on a PCR strategy. Two
partially degenerate primers were designed based on the internal
peptide sequence of TGP1. Using these two primers, a ∼55 bp
fragment was amplified from the first strand cDNAs by reverse
transcriptase PCR (RT-PCR). The DNA sequence between the
two primers encodes a peptide KVGGH which is consistent with
the peptide sequence obtained from direct peptide sequencing.
Based on this DNA sequence, the full length sequence of TGP1
cDNA was obtained using 5′ and 3′ RACE.
Translation of the longest open reading frame (ORF) in the TGP1
full length cDNA sequence produces a 725 amino acid long protein
(the TGP1 cDNA and protein sequences had been deposited into
GenBank with accession no. AF006380). The sequence of this
predicted protein is considered correct and complete for TGP1 for
the following reasons: (i) this predicted protein sequence contains
the peptide sequence obtained from the direct peptide sequencing;
(ii) the predicted molecular weight for TGP1 from the sequence is
83.2 kDa, which is consistent with the SDS–PAGE result (∼80 kDa);
(iii) the amino acid composition of this predicted TGP1 protein
matches the composition data obtained from acid hydrolysis of
TGP1 (data not shown).
TGP1 is a novel protein with unusual sequence features
Analyses of the predicted TGP1 protein sequence showed that
TGP1 has an unbalanced amino acid composition: it is rich in
asparagine (13.9%), lysine (9.4%), glutamine (7.2%) and argi-
nine (7.0%), whereas it has only one tryptophan, two cystines and
five methionines. The richness of basic amino acids (lysine,
arginine and histidine) results in a predicted pI of 10.58, and likely
relates to the DNA binding activity of TGP1. Hydrophobicity plot
of TGP1 showed that TGP1 contains two extensively hydrophilic
and basic regions. One of the two regions is from residue 476 to
residue 603. In this 128 amino acid region, there are 109
hydrophilic residues, and among them, 40 asparagines (33%,
twice the average percentage in the whole TGP1 sequence),
17 glutamines (14%, twice the average), and more strikingly, 33
basic residues (compared with only five acidic residues). Another
hydrophilic and basic region is from residue 251 to 285. The
hydrophilic and basic properties of these regions suggest that they
may serve as the DNA binding sites (domains) for TGP1.
However, none of the known DNA binding motifs were found in
the TGP1 sequence (including the hydrophilic and basic regions).
Comparison of the TGP1 protein sequence with available
databases using BLAST and FASTA programs showed that TGP1
does not share significant homology or similarity with any other
proteins, including many known G-DNA binding proteins, yet is
weakly similar to a number of proteins. An entry with one of the best
scores (P = 0.02) in the BLAST search is the yeast NUF1 protein,
which contains coiled-coil structures and is probably a component
of the yeast nuclear skeleton (40). The GAP alignment (gap creation
penalty: 7; extension penalty: 2) between TGP1 and NUF1 over the
whole sequence showed a 22% identity. In addition to NUF1,
several other proteins with coiled-coil structures, including the
tropomyosin α chain of smooth muscle, paramyosin and myosin
regulatory light chain from different species, were returned in the
FASTA search. However, a secondary structure prediction program
(the PHD program in EMBL) did not predict similar structures for
TGP1. Of note, the BLAST search also returned two yeast G-quartet
binding proteins, G4p1 and G4p2. TGP1 has a region (152–268
amino acids) similar (19% identity, 40% similarity) to a region in
G4p1 (46–162 amino acids) (Fig. 7A). TGP1 also has several short
sequences similar to sequences in G4p2, and one of the short
sequences is within the longer extensively hydrophilic region in
TGP1 (Fig. 7B). However, alignments of TGP1 with either G4p1 or
G4p2 over the whole sequence resulted in much lower (probably
random) similarity. 
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Figure 7. Partial sequence alignments between TGP1 (GenBank accession no.
AF006380) and G4p1 (17) (A), and G4p2 (18) (B). The identity (|) and
similarities (: and .) between residues are indicated.
DISCUSSION
G-DNAs are novel DNA structures whose proposed biological roles
include participation in telomere function, recombination and gene
regulation. These putative roles are still unproven and need further
exploration. One approach is to identify and study proteins that
interact with G-DNA. In this paper, we described the purification,
biochemical characterization and molecular cloning of TGP1, the
first identified Tetrahymena G-DNA binding protein (32).
This study ultimately identified TGP1 as an 83 kDa protein. UV
cross-linking experiments suggested that a protein of mw of
∼61–87 kDa was responsible for the TGP1 activity. During a
three-column purification process, an ∼80 kDa protein was found
in the most highly purified fractions. Renaturation experiments
demonstrated that the ∼80 kDa protein contained TGP1 activity.
Furthermore, the cloned TGP1 cDNA encodes a protein with a
predicted mw of 83 kDa. In addition to the 83 kDa TGP1 protein,
we identified an ∼40 kDa protein which copurified with TGP1
during the three-column purification. Interestingly, renaturation
experiments showed that this 40 kDa protein possessed a G-DNA
binding activity distinct from TGP1. Since the N-terminal peptide
sequence of the 40 kDa protein was not found in the TGP1
sequence (data not shown), the 40 kDa protein is unlikely to be
a degradation product of TGP1, but rather represents an
additional G-DNA binding protein.
The binding specificity of TGP1 was evaluated using the
purified protein. The results of these experiments are consistent
with a previous study (32). The subtle DNA binding specificity of
TGP1 distinguishes it from most known G-quartet binding
proteins. First, TGP1 showed very low affinity for non-G-quartet
nucleic acids (i.e., single- or double-stranded DNAs), whereas
some G-DNA binding proteins are able to bind to these structures.
Such proteins include the yeast telomere protein RAP1 which
binds to the double-stranded yeast telomeric DNA with much
higher affinity (25), and a rat hepatocyte protein qTBP42 which
can bind to single-stranded DNAs (41). Second, TGP1 has a
weaker binding affinity for G-quartet structures formed by RNA,
while some G-quartet binding proteins [e.g., a mouse cytoplasmic
exoribonuclease mXRN1p (42), two yeast protein G4p1 and G4p2
(17,18)] have high affinity for G-RNA. Third, TGP1 has a higher
affinity for parallel-stranded G-DNA than for the antiparallel form.
In contrast, most known G-DNA binding proteins do not
distinguish between these two G-DNA forms. The differences in
binding specificity suggest that G-DNA/RNA binding proteins can
be divided into several subfamilies, each with specificity for
different G-quartet forms. TGP1 could therefore belong to a
distinct parallel G-DNA-binding protein subfamily.
Sequence analyses showed that none of the known DNA
binding motifs were found in TGP1, including a recently
identified Myb-like domain characteristic of some telomere
binding proteins (43,44). This result is not surprising in light of
the fact that TGP1 binds specifically to G-DNA, and has almost
no affinity for double- or single-stranded DNAs. It is reasonable
to predict that novel DNA binding motifs would exist to account
for the specific G-DNA binding activity. Consistent with this
hypothesis, two extensively hydrophilic and basic regions, which
have no similarity to any known DNA/RNA binding motifs, were
identified in TGP1. We propose that the hydrophilic and basic
regions comprise novel G-DNA binding domains. We further
suggest that these novel domains could be shared by other
G-DNA binding proteins to some extent. The weak similarities
between sequences of G4p2 and the longer extensively hydrophilic
region within TGP1 lend support to this hypothesis. Since no
G-DNA specific domains have been identified in any G-DNA
binding proteins thus far, further characterization of these
putative G-DNA binding domains might provide valuable
information on mechanism(s) by which proteins can specifically
recognize the G-DNA structure.
Homology/similarity searches revealed that TGP1 is a novel
protein with very limited similarity to a number of proteins. The
weak similarity between TGP1 and NUF1, the yeast putative nuclear
skeleton protein, suggests that TGP1 may be a component of the
nuclear skeleton (matrix) in Tetrahymena nuclei. Nuclear matrix, the
insoluble non-chromatin scaffold structure of nucleus, has been
thought to be involved in many nuclear events such as chromosome
organization and gene regulation, through associations with
chromosomes (45). The relative abundance of TGP1 [∼1.6 ×
106 molecules/cell, (32)] is consistent with a role for TGP1 as a
structural protein related to the nuclear matrix. One possibility is that
TGP1 may bind to telomeres, where G-DNA structures could form
(46), linking the telomeres to the nuclear matrix, thus helping to
organize the chromosomes. This speculation is supported by data
from other species that link telomere proteins to the nuclear matrix.
For example, the yeast telomere protein RAP1 is associated with the
nuclear matrix (47), and interacts with the SIR4 protein (48), which
is weakly similar to the human nuclear matrix proteins lamin A and
C. In humans, the telomere protein TRF was found to be a
component of the nuclear matrix, and the TRF/telomeric DNA
complexes are associated with the nuclear matrix network (49).
The proposed function for TGP1 in the nuclear matrix is
speculative and does not exclude other possible telomere-related
functions for TGP1. For example, TGP1 may stablize telomere–
telomere interactions that had been observed in many species
(50). Such interactions have been suggested to have a role in
chromosome separation during mitosis (51,52). A mutation in
Tetrahymena telomeric DNA repeat (GGGGTT changed to
GGGGTTTT) caused delayed and abnormal separation between
the sister chromatids during mitosis (52). The mutant chromatids
became elongated up to twice the normal length when they finally
separated, indicating stronger physical association exists between
the mutant chromatids, especially at the telomeres (52). However,
little is known about how telomeres interact with each other. One
of the possible mechanisms is that G-rich strands or 3′ G-overhangs
 Nucleic Acids Research, 1998, Vol. 26, No. 71620
(53–58) of telomeres from different chromosomes can stack
together by forming a G-DNA structure (46). If that is the case,
protein components such as TGP1 could bind to the G-DNA, and
stabilize the interaction between sister chromatids. Any alterations
in the telomere sequence may change the G-DNA/protein
structure, and thus cause problems in chromosome separation.
Preferred TGP1 binding to parallel G-DNA suggests that TGP1
may also be involved in recombination, since parallel G-DNA
structures have long been thought to be involved in recombination
processes (7). It was proposed that four G-rich DNA strands from
sister chromosomes can bind together to form parallel G-DNA
stabilized structures (7). Protein factors that interact with such
structures could therefore have roles in recombination. The yeast
G-DNA specific nuclease KEM1, which recognizes the parallel
G-DNA structure and cuts the single-stranded DNA 5′ to the
G-quartet domain in vitro, was proposed to function in such a way
in meiotic pairing (20). However, in contrast to KEM1, no
nuclease activity was observed for TGP1 (data not shown).
All hypotheses regarding the biological functions for TGP1 and
G-DNA need to be rigorously tested by further studies such as
immunolocalization and gene disruption, and these experiments
are in progress. These studies will further define the function(s)
of TGP1, and should also contribute to the understanding of
biological role(s) of G-DNA in general.
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